Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 13.8B | 13.4B | 13.2B | 14.1B |
Cost of revenue | 8.6B | 7.9B | 7.9B | 8.1B |
Gross profit | 5.3B | 5.5B | 5.2B | 6.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 2.3B | 2.3B | 2.3B | 2.4B |
Other operating expenses | — | — | — | — |
Operating income | 3.0B | 3.2B | 3.0B | 3.5B |
Non operating interest income | ||||
Income | 260.7M | 384.9M | 314.4M | 291.7M |
Expense | 569.9M | 692.5M | 604.8M | 610.7M |
Other income expense | — | — | — | — |
Pretax income | 2.7B | 2.8B | 2.7B | 3.2B |
Tax provision | 842.3M | 913.7M | 853.7M | 1.0B |
Net income | 1.8B | 1.9B | 1.8B | 2.1B |
Basic EPS | 0.6 | 0.6 | 0.6 | 0.7 |
Diluted EPS | 0.6 | 0.6 | 0.6 | 0.7 |
Basic average shares | 3.1B | 3.1B | 3.1B | 3.1B |
Diluted average shares | 3.1B | 3.1B | 3.1B | 3.1B |
EBITDA | 3.7B | 4.1B | 3.8B | 4.3B |
Net income from continuing op. | 1.8B | 5.5B | 1.8B | 2.1B |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |